Related Experiment Videos
Cascade carrier-testing in cystic fibrosis
Theresa Roberts1, Martin J Schwarz, Rowan Kerr-Liddell
1Department of Clinical Genetics, Royal Manchester Children's Hospital, Manchester, UK.
Paediatric Respiratory Reviews
|November 25, 2003
Summary
Genetic carrier testing for cystic fibrosis (CF) is crucial for relatives of affected individuals. An active cascade testing program effectively offers counseling and testing to at-risk family members, ensuring informed reproductive choices.
Area of Science:
- Medical Genetics
- Genetic Counseling
- Public Health
Background:
- Recessive genetic disorders necessitate carrier testing and counseling for relatives to assess reproductive risks.
- Cystic fibrosis (CF) carrier testing has been available since 1989, with recommendations for testing relatives, not general population screening.
- Challenges exist in consistently offering and facilitating carrier testing for relatives of individuals with CF.
Purpose of the Study:
- To describe the implementation and outcomes of an active cascade program for cystic fibrosis carrier testing and counseling.
- To evaluate the effectiveness and user satisfaction of a dedicated service for relatives of CF patients.
Main Methods:
- An active cascade program offering genetic counseling and carrier testing to relatives and partners of CF patients was established.
- The service utilized dedicated staff, a specialist molecular genetics laboratory, and genetic counseling support.
- Target groups included child-bearing age couples/individuals, with discouragement for testing young children and post-reproductive age grandparents.
Main Results:
- The program demonstrated user satisfaction, with minimal reports of feeling pressured into testing.
- The experience of other centers with cascade testing in CF was summarized.
- Consideration is advised when initiating cascades for newborns identified through neonatal screening.
Conclusions:
- Active cascade testing programs are effective in providing genetic counseling and carrier testing to relatives of individuals with cystic fibrosis.
- Such programs can improve access to testing and support informed reproductive decision-making.
- Careful implementation is necessary, particularly concerning extended family members identified through neonatal screening.